Emblem
Fully integrated licensed producer and distributor of medical cannabis and cannabis derivatives.
Employees
Market cap
CAD8.1m
Enterprise valuation
CAD54m (Public information from Oct 2023)
Share price
CAD0.02 AH.TO
Toronto Ontario (HQ)
Financials
Estimates*
CAD | 2018 | 2019 | 2020 | 2022 | 2023 | 2024 | 2025 |
---|---|---|---|---|---|---|---|
Revenues | 3.3m | 16.4m | 44.5m | 43.1m | 42.8m | 74.2m | 85.1m |
% growth | 20976 % | 391 % | 172 % | - | (1 %) | 73 % | 15 % |
EBITDA | (17.9m) | (17.4m) | 164m | (150m) | (11.0m) | - | - |
% EBITDA margin | (537 %) | (106 %) | 368 % | (348 %) | (26 %) | - | - |
Profit | (18.5m) | (39.6m) | (247m) | (170m) | (34.6m) | - | - |
% profit margin | (557 %) | (242 %) | (555 %) | (394 %) | (81 %) | - | - |
Date | Investors | Amount | Round |
---|---|---|---|
N/A | N/A | IPO | |
N/A | N/A | IPO | |
N/A | $43.3m | Post IPO Equity | |
* | $40.3m | Post IPO Debt | |
* | N/A | $13.0m | Post IPO Equity |
* | $22.7m | Post IPO Equity | |
Total Funding | - |
Recent News about Emblem
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.